Campus alert status is green: For the latest UMMS campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search
Page Menu

News from the UMass Diabetes Center of Excellence

  • Friday, July 30, 2021 Insulin Biosimilar Approved by FDA

    FDA Approves Interchangeable Biosimilar Insulin to Potentially Reduce Cost for People to Treat Diabetes

    The FDA has approved the first interchangeable biosimilar insulin for the treatment of diabetes.  It can be substituted by pharmacies without the intervention of the prescribing physician. Will this help to lower insulin prices for people who require this life-saving medication?  Dr. Samir Malkani, Interim Chief of Diabetes at UMass Memorial Health & UMass Diabetes Center of Excellence Education Manager Cheryl Barry, RN, CDCES, offered their thoughts on the matter. LEARN MORE

  • Thursday, July 29, 2021 Virtual Diabetes Camp Jason Kim

    Diabetes Virtual Camp for Future Scientists and Physicians Created by the Family of UMass Diabetes Researcher Jason Kim

    Dr. Kim’s daughters Allison and Lauren are also considering careers in medicine and science. When Lauren’s 2020 summer research internship at Harvard Medical School was canceled due to the COVID-19 pandemic, the family quickly created the Diabetes Virtual Camp to connect students and experts in a virtual internship setting. After successful summer, fall & winter sessions, the 2021 summer session will be sponsored by the American Diabetes Association. LEARN MORE

  • Monday, July 19, 2021 T Cells in T1D

    Means, Motive, and Opportunity: Investigating the Role of Immune Cells in the Development of Type 1 Diabetes

    Sally Kent, PhD, conducts extensive research at UMass Medical School to understand how and why immune cells in people with type 1 diabetes attack their own beta cells.  A newly published article in the scientific journal Frontiers in Immunology specifically investigates the role of T cells at the “scene of the crime,” where the autoimmune attack occurs.  Dr. Kent collaborated with eight other scientists from the United States, Germany, France, and Sweden to co-author “Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes?”   
    FULL STORY

  • Friday, July 16, 2021 Asem Ali, Diabetes care at UMass Memorial

    Care Team Spotlight: Asem Ali, MD - Endocrinologist

    Dr. Asem Ali has been an endocrinologist at the UMass Diabetes Center of Excellence (DCOE) and Associate Professor of Medicine at the University of Massachusetts Medical School since 2014.  He’s the Director of Diabetes Services at Health Alliance Fitchburg Family Practice where spends part of his week leading their care team with the DCOE Community Diabetes Partnership Program.  In addition, he helps to oversee diabetes care for patients at Worcester’s UMass Memorial hospitals.  MEET DR. ALI

  • Thursday, July 08, 2021 Pamela St. Louis

    Researcher Spotlight: Pamela St. Louis

    Pam is a Senior Scientist in the Brehm Lab at the Diabetes Center of Excellence at UMass Medical School. Combining her loves for animals and science, she helps to develop our unique "humanized" mice to observe how a person’s insulin producing beta cells interact with their own immune cells.  The goal is to finally understand where, how and why the autoimmune process takes place. This research provides a pre-clinical model before a potential treatment can advance to human trials.  MEET PAM 

  • Friday, July 02, 2021 Diabetic Foot Clinic

    Diabetes Screenings at UMass Memorial Health Clinic For People Experiencing Homelessness

    The second UMass Diabetic Health Clinic for Worcester’s homeless population was a multidisciplinary outreach event with providers from the Diabetes Center of Excellence, vascular surgery, wound care, podiatry & more. They volunteered to examine people, provided information & resources and scheduled follow-up appointments as necessary.  PHOTOS & FULL STORY

  • Thursday, July 01, 2021 Diabetes Insulin Pump and CGM

    The Latest Blood Glucose Management Tools and Products

    New insulin pumps, infusion devices, continuous glucose monitors and smartphone apps continue to become available. Learn about the latest technology and tools providing self-management options for people living with both type 1 diabetes and type 2 diabetes.  FULL ARTICLE

  • Thursday, June 17, 2021 John Mordes Type 1 Diabetes Research UMass Medical School

    Dr. John Mordes is Studying Genes to Predict Type 1 Diabetes Susceptibility in a Unique Rat Model of T1D

    Recently published data involving the development of a unique rat model provides new insight as to how type 1 diabetes may develop in humans. The collaborative research led by Dr. John Mordes, a physician-scientist at the University of Massachusetts Medical School and UMass Memorial Health, studied the relationship between a couple of genes which have previously been determined to increase the likelihood of a person developing T1D. They also investigated a protein coding gene, that when removed, has prevented diabetes in the rats. 
    LEARN MORE

  • Friday, May 21, 2021 Commander of the Air Force Medical Readiness Agency

    UMass Diabetes Nurse Practitioner Sean Collins Appointed Commander of the Air Force Medical Readiness Agency

    UMass Memorial Diabetes Center of Excellence nurse practitioner and United States Air Force Brigadier General Sean Collins, has once again been called to active duty in Washington, DC.  He’s now serving a leadership role as Commander of the Air Force Medical Readiness Agency.  Learn about his decorated military career and how he balances it with his role as a valued member of our our diabetes care team. 
    FULL STORY

  • Friday, April 30, 2021 Roger Davis Academy of Arts and Sciences

    Roger Davis Elected to The American Academy of Arts & Sciences

    Dr. Davis was elected to the American Academy of Arts & Sciences.  His research on stress signaling pathways are connected to diabetes, heart disease, stroke and cancer.  His work has led to the discovery of new genes that contribute to the development of these devastating diseases.  His impressive resume includes investigator of the Howard Hughes Medical Institute, fellow of the American Academy of Microbiology and the American Association for the Advancement of Science, member of the National Academy of Inventors and the National Academy of Sciences. The Davis Lab is investigating the molecular mechanism by which inflammation contributes to diabetes and working on the design of novel therapeutic strategies.  FULL STORY

  • Thursday, April 29, 2021 Diabetes Proinsulin

    UMass DCOE Scientist Sally Kent Contributed to a Newly Published Study of Proinsulin

    Newly published research in the scientific journal Frontiers in Endocrinology investigates potential immunotherapies for type 1 diabetes using a protein called proinsulin. The UMass Diabetes Center of Excellence laboratory of Sally Kent, PhD, provided essential information and materials.  LEARN MORE

  • Friday, April 16, 2021 Cell Metabolism Insulin 100 Years

    UMass Diabetes Center of Excellence Researchers Recognized in Cell Metabolism's 100 Years of Insulin Issue

    As we approach the 100th anniversary of the discovery of insulin in 1921, the scientific journal Cell Metabolism shared stories of scientists and clinicians whose research has advanced our understanding of insulin, islet biology, insulin resistance and diabetes. Two UMass Diabetes Center of Excellence researchers reflected on the privilege of studying insulin.  FULL STORY   

  • Friday, March 19, 2021 Livongo Study at Umass Memorial

    Clinical Study Evaluates a Remote Glucose Monitoring Program to Help People With Poorly Controlled Type 2 Diabetes

    Newly published data of a randomized crossover trial evaluated a remote monitoring program for people with poorly controlled type 2 diabetes within the UMass Memorial Health Care system. Patients were provided with coaching from diabetes educators who monitored readings of patients’ blood glucose each time they tested and contacted them if their blood glucose was dangerously high or low. LEARN MORE

  • Wednesday, March 03, 2021 Researcher Spotlight: Sushobhana Bandyopadhyay, PhD

    Researcher Spotlight: Sushobhana Bandyopadhyay, PhD

    Dr. Bandyopadhyay is a postdoc in the Brehm Lab. She's studying how and why the autoimmune attack occurs in people with type 1 diabetes. They've started transplanting human cells that were derived from stem cells, into their unique "humanized" mouse models. She conducts experiments to observe interactions between insulin-producing beta cells and immune cells from the same T1D patients.  VIDEO & STORY

  • Tuesday, February 23, 2021 JDRF Stem Cell Research

    JDRF New England Center of Excellence Includes Five UMass Medical School Scientists Working to Cure Type 1 Diabetes

    The newly funded JDRF New England Center of Excellence research collaborative brings together leading scientists working to cure type 1 diabetes. Three simultaneous projects are being worked on to create a cell replacement therapy that would be invisible to the immune system, and provide insulin independence for people living with T1D. 
    ARTICLE & VIDEO

  • Friday, February 19, 2021 David Harlan, MD - Insulin's 100th Birthday

    Dr. David Harlan Celebrates 100 Years Since the Initial Purification & Use of Insulin in Diabetes Therapy with "The Noble and Often Nobel Role of Insulin-Related Research"

    Dr. Harlan kicked off the Stanford Diabetes Research Center Symposium celebrating the 100th anniversary of the purification & use of insulin as a life-saving diabetes treatment. His thorough retrospective describes important roles played by various scientists, including Nobel laureates. Four major themes in his presentation are: good ideas vs. brilliance; the roles that serendipity and persistence played; and unforeseen consequences of these incredible research accomplishments. VIEW VIDEO  

  • Tuesday, January 26, 2021 Tammy Nguyen UMass Medical School Wound Healing

    Tammy Nguyen Received a Vascular and Endovascular Surgery Society Award to Investigate Why People with Diabetes Have Problems with Wound Healing

    Tammy Nguyen, MD, PhD, is analyzing bone marrow to learn why diabetes patients with foot ulcers have a difficult time healing. She received the Vascular and Endovascular Surgery Society’s 2021 Early Career Faculty Research Grant designed to help new vascular surgical investigators initiate projects that will lead to additional funding. She's comparing immune cells from people with diabetes who have had amputations with nondiabetic patients who have had amputations for other reasons.  FULL STORY

  • Friday, January 15, 2021 Virtual Diabetes Camp Jason Kim

    Diabetes Virtual Camp for Future Scientists and Physicians Created by the Family of UMass Diabetes Researcher Jason Kim

    Dr. Kim’s daughters Allison and Lauren are also considering careers in medicine and science. When Lauren’s summer research internship at Harvard Medical School was canceled due to the COVID-19 pandemic last year, the family quickly created the Diabetes Virtual Camp to connect students and experts in a virtual internship setting. After successful summer and fall sessions, they teamed up with the American Diabetes Association to support diabetes research, education and care. LEARN MORE

  • Thursday, January 14, 2021 Sean Collins Soldiers Home

    UMass Diabetes Nurse Practitioner, Brig. Gen. Sean Collins Was Appointed to Board of Trustees for the Holyoke Soldiers’ Home

    In addition to being a nurse practitioner for the Diabetes Center of Excellence at UMass Memorial Medical Center, Sean Collins, PhD, NP, is also has a decorated military career. Air National Guard Brigadier General Sean Collins has been named a member of the Board of Trustees for the Soldiers’ Home in Holyoke. He recently served three months at the Pentagon addressing COVID issues in the early days of the pandemic.  FULL STORY

  • Tuesday, January 05, 2021 Myoung Sook Han diabetes research

    Investigating a Potential Hormone Therapy for Type 2 Diabetes in the Davis Lab at UMass Medical School

    Newly published research from the Davis Lab at the UMass Diabetes Center of Excellence explains a discovery that could lead to a potential therapy for type 2 diabetes and other metabolic diseases. LEARN MORE

  • Friday, December 18, 2020 Shianne Walls UMass Diabetes

    Staff Spotlight: Shianne Walls, Ambulatory Services Representative

    Shianne was nominated by a colleague at the UMass Diabetes Center of Excellence via UMatter Central, a systemwide online recognition platform which gives UMass Memorial caregivers the opportunity to show appreciation for fellow caregivers.  She works full time in the diabetes clinic, while raising three children, ages 6, 13 and 15, and also attending nursing school.  MEET SHIANNE

  • Friday, December 11, 2020 Nuzzy Golf Fundraiser

    The Joseph Nozzolillo Memorial Foundation Surpassed $40,000 in Fundraising for Research at the UMass Diabetes Center of Excellence

    The Joseph “Nuzzy” Nozzolillo Memorial Foundation added a $17,500 donation to their ongoing support of the UMass Diabetes Center of Excellence, raising their three-year total to $40,000.  The third annual Joe “Nuzzy” Nozzolillo Memorial Golf Tournament was held in September, following a socially distant outdoor “Rockin’ for Nuzzy” fundraiser concert over the summer. STORY & PHOTOS

  • Friday, December 04, 2020 Samir Malkani, MD

    UMass Memorial Department of Medicine Diabetes Division Leadership Transition For Patient Care Clinic

    Dr. Samir Malkani has been named Interim Chief of Diabetes, UMass Memorial Department of Medicine.  Dr. Malkani is a Professor of Medicine at UMass Medical School and began treating people living with diabetes at UMass Memorial in 1993 as a postdoctoral fellow.  Since 2001, he's been spending part of his week at Milford Regional Medical Center and was instrumental in building the UMass DCOE Community Diabetes Partnership Program.  Dr. David Harlan will continue serving as co-director of the DCOE, placing an emphasis on his ongoing type 1 diabetes research.  LEARN MORE

  • Monday, November 30, 2020 Silvia Corvera UMass Diabetes

    Protein Commonly Screened For During Pregnancy is Linked to Gestational Diabetes at UMass Medical School

    Research at UMass Medical School shows low levels of a protein commonly seen in screening tests during the first trimester of pregnancy is associated with adipose tissue remodeling, glucose resistance and gestational diabetes in pregnant women. The study, published in Science Translational Medicine, outlines a new role for pregnancy-associated plasma protein A, known as PAPPA, in gestational diabetes, with translational potential as both a diagnostic tool and therapeutic target.  FULL STORY

  • Wednesday, November 18, 2020 Messina Lab Wound Healing Research

    The Messina Lab is Developing a Treatment for Previously Non-Healing Wounds in People with Diabetes

    The laboratory of Louis M. Messina, MD, has received grant funding from the National Institutes of Health (NIH) to test a novel therapy they’ve developed to treat wounds in older adults living with type 2 diabetes.  The Messina Lab already developed and patented a biotherapeutic, which they're now testing in our unique humanized mouse models.  FULL STORY

  • Thursday, October 29, 2020 Micheal Czech and Silvia Corvera

    Re-engineering “Bad Fat” into “Good Fat” as a Therapeutic Approach to Type 2 Diabetes in the Czech & Corvera Labs

    Scientists in the Czech Lab and Corvera Lab at UMass Medical School are using the gene editing tool CRISPR to alter DNA and modify gene function - and developing new methods to modify human fat cells in vitro, then transplanting them as a potential therapy for type 2 diabetes and obesity.  LEARN MORE

  • Thursday, October 22, 2020 Victoria Anderson Diabetes Nutrition

    Care Team Spotlight: Victoria Andersen, Clinical Nutritionist & Diabetes Educator

    Victoria Andersen is a registered dietitian, licensed nutritionist and certified diabetes care & education specialist at the UMass Memorial Diabetes Center of Excellence. She uses her diverse training to help people living with type 1, type 2 and gestational diabetes customize a healthy eating lifestyle to keep their blood sugars within target range. Her long road to Massachusetts went through Minnesota and Seattle.  MEET VICTORIA 

  • Saturday, October 17, 2020 Silvia Corvera Type 2 Diabetes Research

    The Corvera Lab is Examining How Different Body Fat Plays a Role in Type 2 Diabetes

    People with extra fat around their belly are more at risk of developing type 2 diabetes than those who have fat in the lower body. The Corvera Lab is studying how the development and function of fat cells differ in people with and without diabetes. They examine human fat from different locations in the body to study cells which become fat cells. Understanding the differences in genes expressed in these cells from abdominal fat or gluteal fat and how they become different types of fat cells will help elucidate how different fat depots form, and if they vary between people with and without type 2 diabetes. It will also help explain why lower body fat is beneficial, and maybe recapitulate these beneficial effects in ways that can improve health.  LEARN MORE

  • Saturday, October 10, 2020 Cell Reports Guertin Lab Type 2 Research

    Studying Fat Cell Function in the Guertin Lab in an Effort to Develop & Test Therapies for Type 2 Diabetes

    Newly published research in the Guertin Lab at the UMass Diabetes Center of Excellence knocks out a gene, specifically in a precursor cell population, that gives rise to new fat cells, to understand how to make a healthy fat cell. They're studying a signaling pathway called mTOR Complex 2 (mTORC2). A key regulatory input was discovered that helps to establish not only insulin sensitivity, but the ability of fat tissue to use insulin to take up and store energy as lipids. For the first time, this data establishes mTORC2 as a key regulator of a developing fat cell.  FULL STORY

  • Thursday, October 08, 2020 Taylor Boudreau Diabetes

    Care Team Spotlight: Taylor Boudreau, Diabetes Nurse Practitioner

    Taylor splits her time helping people manage diabetes at both the UMass Diabetes Center of Excellence on the University campus in Worcester, as well as in northern Massachusetts at Heywood Hospital in Gardner. She enjoys helping them understand the barriers preventing healthy blood sugars, and putting together a plan to overcome those obstacles. she takes great pride in her patients' results. MEET TAYLOR

  • Saturday, October 03, 2020 Kyounghee Min

    Mello Scholars Recognized for Molecular Research at UMass Medical School in Pursuit of the Advancement of Human Health

    Nobel Laureate Craig Mello presented the annual Mello Scholars awards at a socially distanced ceremony at UMass Medical School. The event recognizes graduate students in the Program in Molecular Medicine with outstanding track records and bright futures. The award comes with one year of funding. One of this year’s recipients is a member of the Czech Lab at the UMass Diabetes Center of Excellence. Learn more about this year's honorees here.

  • Friday, September 25, 2020 Lindsey Gurry UMass Diabetes

    Care Team Spotlight: Lindsey Gurry - Nurse Practitioner & Diabetes Educator

    Lindsey was diagnosed with type 1 diabetes at 18 years old during her senior year of high school. Transitioning to college life was stressful while still learning to manage T1D with insulin injections & blood sugar checks all day. After freshman year at Suffolk University she decided to pursue a career as a nurse practitioner specializing in helping people with diabetes. Lindsey transferred to UMass Boston where she completed her nursing degree. She worked as a full-time nurse for 11 years and became a certified diabetes educator to help people manage diabetes. While working full-time, Lindsey earned her Masters in Nursing degree completing the Nurse Practitioner Program. Today she educates patients living with diabetes who are admitted to UMass Memorial hospitals.  MEET LINDSEY

  • Wednesday, September 23, 2020 Clifford Rosen, MD

    Dr. Clifford Rosen Presented at UMass Endocrine Grand Rounds and Remembered Longtime Mentor and Friend Dr. Lewis E. Braverman

    The UMass Diabetes Center of Excellence and Division of Endocrinology welcomed Clifford Rosen, MD, to present at Endocrine Grand Rounds. Dr. Rosen is the director of clinical and translation research at Maine Medical Center Research Institute, and professor of medicine at Tufts University School of Medicine. His ties to UMass Medical Center date back to his medical residency during the late 1970’s, where a long friendship and working relationship was formed with the late Dr. Lewis Braverman. Learn more about the impressive career of Dr. Braverman and the many lives he touched. Watch Dr. Rosen's Endocrinology Grand Rounds research talk "A New Counter-Regulatory Hormone During Exercise: The Story of Irisin."  ARTICLE & VIDEO

     

  • Wednesday, September 16, 2020 Insulin Rising Cost

    The Growing Need For Health Equity For People Living With Diabetes

    The American Diabetes Association launched #HealthEquityNow, a national platform to ensure all 122 million Americans living with diabetes and prediabetes have access to necessary health resources. The UMass Diabetes Center of Excellence continues to hear people complain that insulin is too expensive. Many have admitted to sometimes skipping doses to make it last longer.  FULL STORY 

  • Friday, September 11, 2020 Jessin Varghese Diabetes Nurse Practitioner

    Care Team Spotlight: Jessin Varghese, MS, FNP-BC

    Jessin has been working as a nurse practitioner at the UMass Diabetes Center of Excellence since 2015. She’s a member of the Inpatient Blood Glucose Management care team, who works with patients living with diabetes while they’re being treated at UMass Memorial hospitals. Learn why she chose diabetes, the differences between inpatient and outpatient diabetes care, and her typical day at work.  MEET JESSIN

  • Wednesday, August 26, 2020 Silvia Corvera Clinical Trial

    Dr. Silvia Corvera Leads a New Clinical Trial to Study the Relationship Between Fat, Diabetes and Obesity

    The location of body fat varies in people and too much fat in the
    belly area is a risk factor for diabetes. The purpose of this
    research is to characterize how fat cells from the abdomen and
    buttock regions are different and to study how these cells are
    different in people with type 2 diabetes.  LEARN MORE

  • Wednesday, August 19, 2020 Cell Metabolism Type 2 Diabetes Research

    The Kim Lab Participated in Newly Published Collaborative Type 2 Diabetes Research That Identified a Potential Oral Treatment

    Type 2 diabetes research in the laboratory of Dr. Jason Kim at the UMass Diabetes Center of Excellence, in a collaborative project led by Dr. Anath Shalev at the University of Alabama at Birmingham and her research team who had discovered a small molecule SRI-37330, have unveiled an exciting new process by which this compound effectively rescues mice from obesity-induced diabetes.  Compared to currently available therapies it could provide an effective new approach to treating type 2 diabetes.  LEARN MORE

  • Thursday, July 30, 2020 Diabetes Prevention Program

    Research Project at UMass Medical School to Improve Prediabetes and Diabetes in Primary Health Care

    Prior to completing their studies at University of Massachusetts Medical School, Dr. Ashley Millette Cote and Dr. Alexandria Capozza completed a capstone research project which analyzed the effectiveness of Diabetes Prevention Programs in Massachusetts.  They also developed an elective class at the medical school to teach future students about the best care available for people living with prediabetes and type 2 diabetes.  FULL STORY

  • Friday, July 24, 2020 Cell Reports July 2020

    Modeling Type 1 Diabetes Using Human Stem Cells in the Brehm and Greiner Labs

    Scientists at the UMass Diabetes Center of Excellence continue to gain new knowledge of type 1 diabetes by studying human tissues and human cells, to recreate the disease in our unique humanized animal models.  Newly published research describes our collaboration with the Melton Lab at The Harvard Stem Cell Institute.  Scientists were recently able to model type 1 diabetes autoimmunity using patient’s blood and stem cell derived beta cells.  LEARN MORE

  • Wednesday, July 15, 2020 Benjamin Nwosu diabetes Umass Memorial

    A Study by Dr. Benjamin Nwosu Shows Continuous Glucose Monitors Reduced Pubertal Hyperglycemia in Type 1 Diabetes

    Uncontrolled high blood sugar in young people with type 1 diabetes is common during puberty. Dr. Nwosu led a newly published study in the Journal of Pediatric Endocrinology and Metabolism that examined blood glucose data of pediatric T1D patients at the UMass Memorial Diabetes Center of Excellence. Results include a significantly lower A1c after one year, in the group that used a continuos glucose monitor.  LEARN MORE

  • Thursday, July 09, 2020 Sally Kent Diabetes Journal Article

    UMass DCOE Scientist Sally Kent Contributed to a Published Article About the Autoimmune Process of Type 1 Diabetes

    UMass Diabetes Center of Excellence scientist Sally Kent's lab is credited with uncovering new information about how autoreactive T cells target beta cells in pancreatic islets. Dr. Kent is encouraged her breakthrough will contribute to the design of therapies for people living with type 1 diabetes. She's one of the authors of a published Perspective article in the July 2020 journal Diabetes which updates and reappraises what scientists have found over the past 30 years examining autoreactive T cell response in T1D.  FULL STORY

  • Wednesday, July 01, 2020 Diabetes Camp Study UMass Memorial

    A Study by Dr. Amy Darukhanavala Compared Blood Sugar Control and Treatment Satisfaction Between Diabetes Camp vs. Home

    Amy Darukhanavala, MD, a pediatric diabetes physician at UMass Memorial’s Diabetes Center of Excellence, led a study comparing the success of continuous glucose monitoring at diabetes summer camp versus at home prior to camp. The research examined blood sugar data and quality of life, based on how the children felt about their diabetes in both settings.  STUDY RESULTS

  • Wednesday, June 17, 2020 Jennifer Wang UMass Diabetes research

    Physician-Scientist Jennifer Wang Uses Stem-Cell Derived Beta Cells to Study the Effects of Viral Infections on Type 1 Diabetes Development

    Enteroviruses encompass a group of viruses that give rise to infectious illnesses which are usually mild. However, if enteroviruses such as coxsackievirus infect the central nervous system or heart, they can cause serious illness. Enteroviral infections are also associated with T1D, but how they contribute to this disease is not well understood. Jennifer Wang's lab is using stem-cell derived beta cells to study virus-driven immunology and beta cell dysfunction, with the ultimate goal of new treatments.  FULL STORY

  • Wednesday, June 10, 2020 Helmsley Grant UMass Diabetes

    UMass Diabetes Center of Excellence Improving Digital Health Solutions with Simplified Data Sharing

    Thanks to support from the Helmsley Charitable Trust through their Diabetes Data Innovation Initiative, the UMass Memorial DCOE is developing digital health solutions to efficiently collect data and train administrative staff to implement the systems. FULL STORY

  • Monday, June 01, 2020 Metformin Recall DiabetesMetformin Recall Diabetes

    What You Need to Know About the Metformin Recall

    The U.S. Food and Drug Administration asked five pharmaceutical companies to voluntarily recall a limited supply of metformin extended-release (ER) tablets 500 mg. Recent tests revealed high levels of N-nitrosodimethylamine (NDMA), which is believed to cause cancer. FDA testing has not shown NDMA in immediate release (IR) metformin products, which is the most commonly prescribed type of metformin. LEARN MORE

  • Tuesday, May 19, 2020 Diabetes Telehealth

    Telehealth May Become the New Normal in Diabetes Care

    Virtual telemedicine has been considered by many over the years to be well-suited for diabetes care. A recent study shows better A1c reduction in people who received telehealth care compared with typical in-person appointments. UMass Memorial patients who have received remote diabetes care during the coronavirus pandemic have been overwhelmingly positive about the process. Another published study claims people with type 1 diabetes have combined telehealth and technology with proper blood glucose management and monitoring to achieve better outcomes during the pandemic, as patients avoid in-person visits. FULL STORY

  • Thursday, May 14, 2020 Type 1 Diabetes Pancreas Study

    Dr. David Harlan Collaborated on a Newly Published Study Investigating Smaller Pancreases in People with Type 1 Diabetes

    UMass Diabetes Center of Excellence co-director David Harlan, MD, participated in newly published research that further characterized pancreases from adult donors with type 1 diabetes compared with similarly aged donors without diabetes. The study found the pancreases from those with both longstanding and recent-onset T1D to be approximately 45% smaller than pancreases from donors without diabetes.  To learn more about the study and its other findings, check out the FULL STORY

  • Tuesday, May 05, 2020 Beige Fat Study in Cell Reports

    Type 2 Diabetes Research in the Czech Lab Studies Beige Fat to Potentially Increase Metabolism

    Type 2 diabetes research in the UMass Diabetes Center of Excellence laboratory of Michael Czech, PhD, is studying the behavior and function of various fat cells, with the goal of improving metabolism for a potential obesity therapy. New data from one of their recent studies was published in the journal Cell ReportsFULL STORY

  • Friday, April 24, 2020 COVID-19 CGM

    Continuous Glucose Monitors Now Permitted at UMass Memorial to Monitor Diabetes Patients and Protect Hospital Workers During the COVID-19 Pandemic

    The Food and Drug Administration recently allowed continuous glucose monitors to be used in hospitals during the pandemic to help health care workers monitor diabetes patients while reducing their own exposure to the coronavirus. This week, UMass Memorial began using them to monitor the blood sugar of UMass Memorial's COVID-19 patients with diabetes. In recent years, the UMass Diabetes Center of Excellence has revolutionized blood glucose management for all people living with diabetes who are admitted to Worcester’s UMass Memorial hospitals.  LEARN MORE

  • Tuesday, April 14, 2020 Alan Derr Diabetes Research

    Alan Derr Named Cammett Scholar in Type 1 Diabetes Research at UMass Medical School

    Alan Derr was named the Cammett Scholar for type 1 diabetes research, supported by a generous gift from UMass Diabetes Center of Excellence Visiting Advocacy Committee member John Cammett. Alan's role as a bioinformatician is to analyze the vast volume of data generated during the study of human insulin producing beta cells and the immune cells that attack human islets in people living with diabetes. FULL STORY

  • Thursday, April 02, 2020 New Data Published from the Guertin Lab About mTORC2 Signaling in Brown Adipocytes

    New Data Published from the Guertin Lab About mTORC2 Signaling in Brown Adipocytes

    Type 2 diabetes metabolism research in the Guertin Lab examined time dependent changes in the mTORC2 signaling pathway in mature brown adipocytes (fat tissue). LEARN MORE

  • Tuesday, February 25, 2020 Wally Gilbert and David Harlan

    David Harlan Interviews Nobel Laureate Wally Gilbert About His Pioneering Work in DNA Sequencing That Led to the Creation of the First Genetically Engineered Human Insulin

    David Harlan, MD, interviewed Nobel Prize laureate Wally Gilbert, PhD, 40 years after the first human insulin for diabetes treatment was genetically engineered, thanks in part to his pioneering work in DNA sequencing. Dr. Gilbert is now an accomplished artist and after the interview they toured his impressive art studio in Boston. WATCH THE VIDEO

  • Tuesday, February 18, 2020 Daniel Amante and Adarsha Bajracharya

    ID PLUS Care program developed to help at-risk type 2 diabetes patients within UMass Memorial receive the care they need

    A new program within the UMass Diabetes Center of Excellence is tracking patients at-risk for negative outcomes due to gaps in care by identifying their difficulties and guiding them towards available services and resources to control their diabetes. The ultimate goal is to prevent or reduce the risk of complications, lower healthcare costs, and improve quality of life by encouraging self-care diabetes management. LEARN MORE

  • Friday, February 14, 2020 Samantha Barry and Kristin MacGregor

    Psychosocial screening of youth with type 1 diabetes at the UMass Memorial Diabetes Center of Excellence

    The American Diabetes Association continues to recommend screening people living with type 1 diabetes for psychosocial health concerns. The UMass Memorial Diabetes Center of Excellence is one of few diabetes clinics in the country which currently employs multiple health psychologists on the diabetes care team. The pediatric diabetes care team at UMass Memorial developed and implemented a successful pilot screening program. The results were published in Journal of Pediatric Psychology.  FULL STORY

     

  • Friday, February 07, 2020 Richard A. Siller, PhD  UMass Medical Diabetes

    Glass Family Fellowship in Diabetes Research Established at the UMass Medical School Diabetes Center of Excellence

    The UMass Diabetes Center of Excellence established The Glass Family Fellowship in Diabetes Research, through a gift from Scott and Patricia Glass. It was awarded to Richard A. Siller, PhD, a postdoctoral research fellow in the Maehr Lab. He's eager to collaborate with his fellow lab members to work toward creating a fully functional human thymus over the the next two years at the University of Massachusetts Medical School.  FULL STORY 

  • Friday, February 07, 2020 Davis Lab Sheds Light on Complications From High Blood Glucose and Excess Body Fat Which Lead to Type 2 Diabetes

    Davis Lab Sheds Light on Complications From High Blood Glucose and Excess Body Fat Which Lead to Type 2 Diabetes

    A new study in the Davis Lab on causes of metabolic syndrome was published in The Proceedings of the National Academy of Sciences, the official journal of the National Academy of Sciences. Data obtained from this research provides insight into some type 2 diabetes risk factors including high blood glucose and obesity.  READ MORE

  • Monday, February 03, 2020 mTORC2 signaling study published in Nature Communications

    mTORC2 signaling study published in Nature Communications

    A study by Camila Martinez Calejman, PhD, published in the journal Nature Communications revealed an unexpected link between mTOR signaling and the synthesis of Acetyl-CoA, a molecule with critical roles in carbohydrate and lipid metabolism and the epigenetic control of gene expression.  It describes the importance of this link in brown adipose tissue, but the implications may extend to understanding other aspects of type 2 diabetes and cancer.  FULL STORY

  • Sunday, February 02, 2020 Metabolic Network connects UMass Medical School metabolism researchers

    Metabolic Network connects UMass Medical School metabolism researchers

    Diabetes Center of Excellence scientists are part of the UMass Medical School Metabolic Network that connects the many laboratories and researchers who study various facets of metabolism and metabolic regulation on campus. It provides another opportunity to learn new biology, find potential collaborators and advance new technologies.  LEARN MORE 

  • Wednesday, January 29, 2020 Rene Maher Type 1 Diabetes

    Creating a thymus to improve the fight against type 1 diabetes

    In a clinical trial the Maehr Lab is creating human thymus glands using stem cells from the blood of volunteer participants. They'll be inserted into our humanized immune systems, along with insulin producing beta cells and immune cells created from the stem cells of those same blood donors. This will allow our scientists to study the interaction between an individual’s own cells, to investigate how and why the autoimmune attack is taking place. Once it’s determined what’s causing type 1 diabetes, we can then begin to test therapies within our humanized immune models.  LEARN MORE

  • Tuesday, January 21, 2020 FACEB Journal Harlan Lab

    The Harlan and Greiner Labs Developed a New Method to Study Human Cells and Tissue That Improves Type 1 Diabetes Research

    A new technique to study human cells and tissues was recently developed at the UMass Diabetes Center of Excellence. It’s another step forward in the continued effort to examine the insulin producing beta cells of humans living with type 1 diabetes and to learn more about the autoimmune attack associated with the disease. The new method allows our scientists to recover and further examine sufficient amounts of living human cells that they previously transplanted into our novel human immune models.  LEARN MORE 

  • Friday, January 17, 2020 Michael Czech UMass Diabetes

    Type 2 diabetes research studying the behavior and function of the cells that make up adipose tissue

    Type 2 diabetes research in the laboratory of Michael Czech, PhD, includes studying the behavior and function of the various cells that make up adipose tissue, with a goal of improving systemic metabolism in obesity.  They contributed some of their RNAi technology to a study published in The Journal of Immunology.  FULL ARTICLE  

  • Wednesday, December 11, 2019 Sally Kent Type 1 Diabetes Research

    Sally Kent Named Fuller Foundation Term Chair in Diabetes

    Sally C. Kent, PhD, has been named the George F. and Sybil H. Fuller Foundation Term Chair in Diabetes. Dr. Kent studies autoimmune response in type 1 diabetes. Her lab is credited with uncovering new information on how autoreactive T cells target beta cells in islets, a breakthrough that will contribute to the design of therapies for people with type 1 diabetes.  FULL STORY

  • Tuesday, November 26, 2019 Current Diabetes Report Adyposite

    Guertin Lab review on the metabolism of fat cells in type 2 diabetes published in Current Diabetes Reports

    Guertin Lab graduate student Wen-Yu Hsiao presents an interesting perspective based on recent findings about what makes a fat cell “healthy” and why.  Their research examines how the metabolism of adipocytes impacts blood glucose and insulin resistance especially in people living with obesity and/or type 2 diabetes.  READ MORE

  • Friday, November 22, 2019 Rachel Armenti

    Care Team Spotlight: Rachael Armenti, RN, CDCES

    Rachael is a certified pediatric nurse and certified diabetes care and education specialist (CDCES). Her interest in working with children living with diabetes began while she was first studying to become a nurse at Worcester State University, and spent time at a camp for kids with diabetes. The most gratifying part of her job is helping families get through the overwhelming and frightening process of diagnosis, to the first few clinic appointments and eventually feeling confident that they can manage the disease.  READ MORE

  • Wednesday, October 16, 2019 Conversation Maps for Diabetes Education

    Mapping your plan to control blood glucose with the help of diabetes education

    The UMass Diabetes Center of Excellence education workshops use Conversation Maps® to teach a variety of diabetes topics to help people make lifestyle changes as part of their self-management.  LEARN MORE

  • Monday, October 07, 2019 Flu shots and diabetes care

    Importance of a flu shot for people living with diabetes

    People living with type 1 and type 2 diabetes, even when well-managed, are at high risk of serious flu complications. September or October is considered the best time to get the vaccine. The flu shot is a safe and effective way to prevent or reduce the severity of previously mentioned complications.  LEARN MORE

  • Friday, September 27, 2019 Carl H. June, MD, pioneer of CAR T Cell Immunotherapy

    Carl H. June, MD, pioneer of CAR T Cell Immunotherapy

    Dr. David Harlan welcomed his longtime friend and fellow distinguished physician/scientist, Carl H. June, MD, to speak at the University of Massachusetts Medical School Department of Medicine Grand Rounds. They worked closely throughout the 1990's when they led the U.S. Navy’s “Immune Cell Biology Program." Dr. June is director of the Center for Cellular Immunotherapies at the University of Pennsylvania Medical School, and is best known for his pioneering work developing CAR T-cell therapy for the treatment of leukemia. FULL VIDEO

  • Thursday, September 26, 2019 Jinglian Yan UMass Diabetes Wound Healing Research

    The Messina Lab is Developing Blood Stem Cell Approaches to Impaired Diabetic Wound Healing

    The Messina lab is studying impaired wound healing resulting from type 2 diabetes. They've found that diabetes impairs wound healing by causing an injury to blood stem cells that affects a particular white blood cell which is the most important cell in the body’s response to a diabetic ulcer.  Loss of limbs is a major fear of people with uncontrolled blood sugars. This research is exploring a blood stem cell-based therapeutic approach to reverse what is one of the most feared complications of diabetes.  FULL STORY 

        

  • Friday, September 20, 2019 Silvia Corvera Adipocyte Research

    New research in the Corvera lab discovered new fat cells with specialized functions in the metabolism of the human body

    Dr. Corvera’s laboratory determined that there are more types of fat cells in the human body than originally thought. Prior research had shown two types of fat cells, white and beige. This new research uncovered at least five types of human fat cells which play different roles in how they affect metabolism.  They're now investigating human cell therapy, which consists of using the body’s own cells to increase metabolism, as a possible treatment for type 2 diabetes or its complications.  FULL STORY

  • Wednesday, September 18, 2019 diabetes peer mentor study

    Development of a peer mentor support measure for parents raising youth with type 1 diabetes and youth with T1D

    A new study at UMass Medical School is designed to develop a questionnaire about peer mentor support for parents of children with type 1 diabetes, as well as young adults who are living with T1D. A peer mentor is a person who provides support and advice on diabetes management. Participants in this study will receive a $25 gift card as a thank you for partaking in each part of the study.  LEARN MORE

  • Friday, September 13, 2019 Stella Lopez UMass Memorial Diabetes

    Care Team Spotlight: Stella Lopez, PsyD

    Dr. Lopez specializes in child and family health psychology. She provides bilingual therapy (English and Spanish) and enjoys helping people of all ages to achieve measurable outcomes with type 1 or type 2 diabetes. The UMass DCOE is one of a small number of diabetes centers within the U.S. that has health psychologists as part of the care team.  MEET DR. LOPEZ  

  • Thursday, September 05, 2019 Brehm lab islet encapsulation device research

    Brehm and Greiner laboratories testing islet encapsulation device in collaboration with Lockheed Martin & JDRF Research

    The goal of this research is to create an implantable cell replacement device to be used as a therapy for people living with type 1 diabetes. Insulin-producing beta cells would be encapsulated in the device to protect the cells from the autoimmune attack, while also allowing those protected cells to survive and function.  FULL STORY

  • Sunday, September 01, 2019 Fernanda Costa - UMass Diabetes

    Care Team Spotlight: Fernanda Costa, RN

    Fernanda Costa, RN, joins the UMass Diabetes Center of Excellence with years of experience serving the Hispanic type 2 diabetes community. She’s fluent in Spanish and Portuguese, which will allow her to speak to our Hispanic and Latino patients in their native language. Costa takes pride in the fact that she has successfully educated many in this high-risk population, helping them to lower their A1c’s, control their blood sugars, and decrease their risk of future health complications.  FULL STORY

  • Wednesday, August 28, 2019 2nd Annual Memorial Golf Tournament to Benefit UMass Diabetes Center of Excellence

    2nd Annual Memorial Golf Tournament to Benefit UMass Diabetes Center of Excellence

    The second annual Joe “Nuzzy” Nozzolillo Memorial Foundation golf tournament raised $12,000 for the UMass Diabetes Center of Excellence, surpassing their inaugural donation of $10,500.  Joe's family and friends are grateful for the care he received and they want to help other people in the area living with diabetes. They presented the check while touring the UMass DCOE research labs  LEARN MORE

  • Saturday, August 24, 2019 Diabetes CGM Article

    Continuous Glucose Monitors and Children with Type 1 Diabetes

    Parents of young children living with type 1 diabetes were asked about the pros and cons of using continuous glucose monitors.  They described the benefits and the challenges.  We asked members of our pediatric diabetes care team their thoughts.  LEARN MORE  

  • Wednesday, August 21, 2019 Care Team Spotlight: Alicia Warnock, MD

    Care Team Spotlight: Alicia Warnock, MD

    Dr. Warnock joins the UMass Diabetes Center of Excellence following 12 years of service in the United States Navy. She specializes in both type 1 and type 2 diabetes management, insulin pump therapy, obesity, weight gain and regain. In 2018 she was deployed for a three-month humanitarian mission in Guatemala and Honduras, where she contributed to 15,500 patient encounters. Learn about what attracted her to UMass Memorial.  FULL STORY

  • Thursday, July 25, 2019 Kristin MacGregor studied the impact of integrated behavioral healthcare in diabetes and the data shows measurable benefits

    Kristin MacGregor studied the impact of integrated behavioral healthcare in diabetes and the data shows measurable benefits

    Dr. MacGregor conducted the first known study of its kind to evaluate the clinical benefit of having a behavioral psychologist who specializes in diabetes working within a diabetes clinic.  Read about why she believes it can potentially make a substantial positive impact on people’s diabetes management and outcomes.  FULL STORY

  • Saturday, June 22, 2019 David Harlan Endocrine Society

    Dr. David Harlan Presents "Going Beyond Insulin in Type 1 Diabetes" at the Endocrine Society's Annual Fellows Conference

    Dr. Harlan was invited to speak at the Endocrine Society's Fellows Series: Type 1 Diabetes Care and Management.  His talk titled "Going Beyond Insulin: Emerging Options for T1D" presented options beyond insulin therapy for people living with diabetes, including GLP-1 and SGLT use.  LEARN MORE

  • Thursday, June 20, 2019 Dr. Juan Ding UMass Memorial Diabetes Eye Specialist

    Walk-In Diabetes Eye Care Available for Diabetes Patients at UMass Memorial

    UMass Memorial offers convenient eye exams for patients with diabetes.  The 5-day a week clinic provides easy access to annual eye exams for our adult and pediatric diabetes patients while they’re already on campus for their diabetes related appointments.  LEARN MORE

  • Friday, June 14, 2019 UMass Diabetes Center of Excellence at the American Diabetes Association's 79th Scientific Sessions

    UMass Diabetes Center of Excellence at the American Diabetes Association's 79th Scientific Sessions

    The UMass DCOE was well represented at the American Diabetes Association’s 79th Scientific Sessions in San Francisco, California.  Our team included award recipients, speakers and research presenters.  LEARN MORE

  • Wednesday, June 05, 2019 Grant Awarded to Improve Inpatient Diabetes Care at UMass Memorial Hospitals

    Grant Awarded to Improve Inpatient Diabetes Care at UMass Memorial Hospitals

    The second annual Herman G. Berkman Diabetes Clinical Innovation Fund grant has been awarded to Leslie J. Domalik, MD and co-investigator Asem Ali, MD.  Read about their project, intended to improve blood glucose control for all patients admitted to UMass Memorial hospitals who are living with diabetes.  FULL STORY

  • Monday, April 08, 2019 Laura Alonso honored with election into the American Society for Clinical Investigation

    Laura Alonso honored with election into the American Society for Clinical Investigation

    Laura Alonso, MD, The George F. and Sybil H. Fuller Term Chair in Diabetes, Director of Beta Cell Biological Studies at the UMass Diabetes Center of Excellence, has been elected to the American Society for Clinical Investigation (ASCI).  One of the nation’s oldest and most prestigious medical honor societies, ASCI supports the work of top physician-scientists whose biomedical research translates findings in the laboratory to the advancement of clinical practice.  LEARN MORE

  • Friday, March 29, 2019 Harlan and Kent Labs Resolved a 30 Year Old Debate by Locating Beta Cells in People with T1D Which Express Important Immune Pathway Gene Products

    Harlan and Kent Labs Resolved a 30 Year Old Debate by Locating Beta Cells in People with T1D Which Express Important Immune Pathway Gene Products

    Studying the islets of people with type 1 diabetes, the laboratories of David Harlan, MD and Sally Kent, PhD definitively put to rest a three decades old debate about whether beta cells express important immune genes called “human leukocyte antigen class II” (HLA Class II).  LEARN MORE 

  • Wednesday, March 27, 2019 Nancy Sidhom UMass Memorial

    Care Team Spotlight: Nancy Sidhom, Nurse Practitioner

    Nancy Sidhom has been a nurse practitioner at the UMass Diabetes Center of Excellence since 2013. She enjoys partnering with patients to help them better manage daily life with diabetes.  Nancy has a passion for proper nutrition and exercise, and strongly believes they are the foundation to proper diabetes self-management.  LEARN MORE  

  • Friday, March 22, 2019 Alonso Lab Demonstrates the Accuracy of BrdU Labeling to Measure Beta Cell Replication

    Alonso Lab Demonstrates the Accuracy of BrdU Labeling to Measure Beta Cell Replication

    A study published by the laboratory of Laura C. Alonso, MD, confirms the fidelity of a widely used technique to measure beta cell replication, despite doubt by some in the field.  The ultimate goal of Laura Alonso's research is to determine approaches to make more beta cells, so as to prevent or treat diabetes.  LEARN MORE

  • Tuesday, March 19, 2019 Benjamin Nwosu diabetes Umass Memorial

    Benjamin Nwosu Examines Cholesterol at Puberty in Type 1 Diabetes

    A new study by Benjamin Nwosu, MD, correlates the phenomenon known as partial clinical remission in children newly diagnosed with type 1 diabetes with cholesterol levels when they reach puberty.  FULL STORY

  • Friday, February 22, 2019 Nicole Gray Certified Child Life Specialist

    Care Team Spotlight: Nicole Sauvé, Certified Child Life Specialist

    The Certified Child Life Specialist at the UMass Memorial Diabetes Center of Excellence supports children and families beginning at the very first office appointment. She works closely with the pediatric diabetes care team to provide age appropriate support and interventions.  LEARN MORE

  • Monday, February 04, 2019 Research in the Brehm and Davis Laboratories Uncovered New Memory T Cells Data

    Research in the Brehm and Davis Laboratories Uncovered New Memory T Cells Data

    Apoptosis of CD8 T cells is an essential mechanism that maintains immune system homeostasis, prevents autoimmunity, and reduces immunopathology.  Research from the Brehm, Greiner and Davis laboratories at the UMass Diabetes Center of Excellence, was published in The Journal of ImmunologyFULL STORY

  • Friday, February 01, 2019 Silvia Corvera Lab Adipocyte studies

    Corvera Lab Continues to Create "Good Fat" as a Potential Therapy for Type 2 Diabetes

    The laboratory of Silvia Corvera, MD, was featured on WCVB-TV/ABC in Boston and WJAR-TV/NBC of Providence about their research into transforming white fat into beige fat, to harness its ability to burn energy, accelerate metabolism and fight disease.  FULL STORY AND VIDEO 

  • Thursday, January 10, 2019 Rachel Stamateris diabetes beta cell research

    MD/PhD Candidate Rachel Stamateris Named Ruth L. Kirschstein Fellow

    Rachel Stamateris, an MD/PhD candidate at University of Massachusetts Medical School, was awarded a prestigious Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship for dual-doctoral degree students, from the National Institute of Diabetes and Digestive and Kidney Diseases. Her fellowship experience is intended to enhance Rachel’s integrated research and clinical training as predoctoral student. Over the next four years, this award will help to sponsor her research and promote her development into a productive, independent physician/clinician-scientist.  READ MORE

  • Tuesday, December 18, 2018 New research in Harlan lab discovered a rare genetic defect that affects human beta cell function

    New research in Harlan lab discovered a rare genetic defect that affects human beta cell function

    Isolating donated islets from a young man who had been treated for 17 years for presumed T1D, scientists found a rare genetic defect had caused his beta cells to function improperly.  Findings were published in The Journal of Clinical Investigation.  LEARN MORE

  • Thursday, December 06, 2018 New beta cell biomarker discovered in research involving Greiner lab: What does it mean for future diabetes research?

    New beta cell biomarker discovered in research involving Greiner lab: What does it mean for future diabetes research?

    The UMass DCOE is among a few in the world studying human beta cells, the insulin producing cells found only in the pancreas.  The lab of DCOE co-director Dale Greiner, PhD, provided unique immunodeficient mice that allowed for the in-vivo imaging studies which identified a new biomarker for beta cells.  Findings are published in Cell Metabolism, December 2018.  FULL STORY

  • Tuesday, November 13, 2018 New data about the "humanized" type 1 diabetes mouse models developed by collaborations in Greiner and Brehm labs

    New data about the "humanized" type 1 diabetes mouse models developed by collaborations in Greiner and Brehm labs

    The Brehm and Greiner labs study human immune responses pathways for potential type 1 diabetes therapies.  "Lack of acute xenogeneic graft-versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression," published in The FASEB Journal.   LEARN MORE

  • Friday, November 02, 2018 UMass Diabetes Center of Excellence patient care clinic receives a $10.5K gift from grateful family

    UMass Diabetes Center of Excellence patient care clinic receives a $10.5K gift from grateful family

    The First Annual Joe “Nuzzy” Memorial Golf Tournament raised $10,500, which was generously donated to the UMass Memorial Diabetes Center of Excellence (DCOE), to be used for continued patient care.  The family wants the money to help others being treated for diabetes at UMass Memorial.  They recently toured our research laboratories, and were impressed with what they saw.   
    FULL STORY

  • Monday, October 29, 2018 Micheal Czech and Silvia Corvera

    Michael Czech and Silvia Corvera receive $2.5 million grant to advance potential therapy for type 2 diabetes

    Silvia Corvera, MD, and Michael Czech, PhD, are investigating whether technologies developed in their labs will harness beige fat’s ability to burn energy and accelerate metabolism in order to improve the body’s response to sugar and lower blood glucose levels.  READ MORE

  • Wednesday, October 24, 2018 Liz Dickinson Diabetes UMass Memorial

    Care Team Spotlight: Elizabeth Tinios, DNP, FNP-C, CDCES

    One third of hospitalized patients have diabetes. Our inpatient team sees the many who already have diabetes while undergoing surgeries or procedures, or are being treated for another chronic illness or health complication. They also work closely with people getting diagnosed with diabetes for the first time, teaching everything needed to leave with “diabetes survival skills.” Our inpatient team ensures a smooth transition home by coordinating medication prescriptions and follow-up appointments.  LEARN MORE

  • Tuesday, August 28, 2018 How virus triggers type 1 diabetes

    Jennifer Wang Receives Funding Grant to Continue Studying How Viruses Trigger Type 1 Diabetes

    Infectious disease and immunology expert Jennifer Wang, MD hopes to move closer to better understanding type 1 diabetes by working with a new animal model to identify pathways which could be stopped in order to prevent the disease from developing.  FULL STORY

  • Tuesday, August 07, 2018 Unexpected cell population slows down fat cells

    Unexpected cell population slows down fat cells

    Fat tissue has a remarkable capacity for growth. David A. Guertin, PhD, explains why his latest research of a fat-precursor cell which unexpectedly functions to suppress adipocyte production, is exciting to the future of combating obesity.  READ MORE

  • Thursday, July 12, 2018 Kristin MacGregor Umass Memorial Diabetes

    Why Language is Important in Diabetes Management

    Words used to describe something shapes the way others perceive and value that thing.  The culture in diabetes tends to be the disease defines the person, such as, “he/she is a diabetic.”  Changing that language to “he is living with diabetes” or “she is thriving with her diabetes care” can make a world of difference.  “A1c and blood glucose numbers should simply be used as data to devise a treatment plan and action plan.  Not a definition of the person,” says Kristin L. MacGregor, PhD, a behavioral psychologist at the UMass Diabetes Center of Excellence. “The truth is, you have the power to manage the disease, it doesn’t control you.”  READ THE ENTIRE ARTICLE

  • Monday, July 09, 2018 Cheryl Barry, RN Diabetes Education

    Diabetes Education Offers Many Benefits

    Diabetes education has been shown to lower A1c by as much as 1% (similar to adding a medication but without the side effects). Research shows that people who have received diabetes education are more likely to utilize primary care and preventative services, take medications as prescribed and control their blood glucose, blood pressure, and cholesterol levels. As a result, those people have lower health costs.  The UMass Memorial Diabetes Center of Excellence offers an extensive education program covering a variety of topics. Both one-on-one sessions and group workshops are available.  LEARN MORE